Updated Recommendation
A new evidence synthesis was published:2015, Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV
View latest version (2015)Bibliographic Info
Recommendation
Recommended in favor
Strong
Certainty of evidence
Low
antiretroviral therapy (ART) should be initiated in all individuals with HIV regardless of WHO clinical stage or CD4 count with priority of the following groups: Individuals coinfected with HIV and hepatitis B virus (HBV) with evidence of severe chronic liver disease
Notes and Remarks
There are no special clinical ART recommendations specific to any key population. However, because of stigma, discrimination and marginalization, they frequently present late for treatment
Also Featured In
This recommendation also appears in the following guidelines:
Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations
Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations